EVP, CLO, Alkermes, Inc.
David Joseph Gaffin is Executive Vice President, Chief Legal Officer, Chief Compliance Officer, and Secretary at Alkermes plc, a biopharmaceutical company focused on developing products for neurological and psychiatric disorders.[[1]](https://www.insidertrades.com/alkermes-plc-stock/david-joseph-gaffin/)[[2]](https://stockanalysis.com/stocks/alks/company/)[[3]](https://www.zoominfo.com/p/David-Gaffin/1649922757) He oversees all legal, intellectual property, and healthcare compliance operations, with over 20 years of legal practice and 19 years in the biopharmaceutical industry.[[3]](https://www.zoominfo.com/p/David-Gaffin/1649922757) Gaffin joined Alkermes in 2005 as Director, Deputy General Counsel, progressing through roles including Senior Director (2009-2011), Vice President and Deputy General Counsel (2011-2014), Vice President and U.S. General Counsel (2014-2016), Senior Vice President and Chief Legal Officer of Alkermes, Inc. (2016-2018), and his current positions since March 2018.[[1]](https://www.insidertrades.com/alkermes-plc-stock/david-joseph-gaffin/)[[3]](https://www.zoominfo.com/p/David-Gaffin/1649922757) Prior to Alkermes, he served as Assistant General Counsel at Biogen Inc., handling product-related legal counsel, compliance, and licensing transactions.[[1]](https://www.insidertrades.com/alkermes-plc-stock/david-joseph-gaffin/)[[3]](https://www.zoominfo.com/p/David-Gaffin/1649922757)
Gaffin holds a Bachelor of Arts in Social Studies from Harvard College, a Master of Business Administration from J.L. Kellogg Graduate School of Management, and a Juris Doctor from Northwestern University School of Law.[[3]](https://www.zoominfo.com/p/David-Gaffin/1649922757) His annual salary is approximately $1,150,000, and he recently sold 14,000 shares of Alkermes stock on July 29, 2021, at $26 per share, retaining 88,597 shares afterward.[[1]](https://www.insidertrades.com/alkermes-plc-stock/david-joseph-gaffin/)
View full insider profile →
